Biotechnology
Johnson & Johnson Might Need a Band-Aid Ahead of Earnings
A rally in the shares stalled around $180 in December and early January.
Bearish Bets: 3 Nasdaq Giants You Should Think About Shorting This Week
These stocks are displaying bearish tendencies based on their technical patterns.
This Small Pharma Company Could Develop Into a Nice Trade
Let's see how to trade GlycoMimetics, a clinical-stage drug developer focused on a type of cancer treatment.
Incyte Gets a Quantitative Upgrade
We have two price target areas for this biopharmaceutical firm.
Why Are Insiders Buying These 2 Stocks?
An oncology and a oil & gas concern, new names on my list, have my attention.
As Celldex Recovers, Here's My Strategy
Let's check the charts on this clinical stage drug developer.
2 Momentum Trades Showing Worst to First Action
These names are off to good starts to 2023 and could have more room to run.
Moderna Shares Surge on Promising Vaccine Results
Let's check the charts and indicators.
3 Potential Biotech Buyout Targets
There are signs that M&A deal activity will pick up in the sector after a couple of subpar years.
Could These Biotechs Be the Top Performers in 2023?
Industry experts share their favorite biotech plays for this year.